Primary prevention of Cardiovascular Diseases among the Middle aged and the Elderly

Author:

Omer Naglaa Mohammed Ahmed Abdelrahim,Yousuf Wafaa,Mansouri Noof

Abstract

Aim: To define the best practice guidelines for primary prevention of cardiovascular diseases in middle age individuals as well as the elderly. Study design and Methodology: Narrative review study for RCT, clinical trials and systematic review studies published in English language from 2003-2018; in middle age individuals as well as the elderly. Search was conducted in Pubmed and Google Chrome. Terms used for searching were (best practice guidelines) and (primary prevention of cardio-vascular disease). Results: The total number of study search items was 2020 studies and after filtering them, the matching studies were 70: 38 studies were excluded whereas 32 studies were included. Six studies were about statins therapy in primary prevention of CVD in the elderly. Five studies were about statin benefits for primary prevention of cardiovascular disease in middle age individuals. Nine studies were about non-statin therapy. Five studies were about blood pressure control and primary prevention of cardiovascular disease. Seven studies were about aspirin for primary prevention of cardiovascular disease in diabetics. Conclusion: Statins are beneficial for primary prevention of cardiovascular disease in middle age individuals as well as the elderly who had dyslipidemia or were diabetic aged 40-75 years, or 10-years CVD risk =>7.5% according to AHA/ACC, or =>10% in accordance with the guidelines for both NICE and USPSTF. There is no definite evidence for non-statin therapy benefit for primary prevention of CVD but it can be used in hypercholesterolemia patients or high CVD risk patients who do not tolerate statins or have not responded to the maximum dose of statins. There was no evidence for aspirin benefit in primary prevention of CVD in diabetics. Immediate blood pressure control is important in the primary prevention of CVD in hypertensive patients with high cardiovascular risk. Key words: Cardiovascular diseases, middle aged, elderly

Publisher

Medi + World International

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3